2 studies found for:    12037148 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: mAb hOKT3gamma1(Ala-Ala), Teplizumab;   Drug: Placebo Arm
2 Unknown  Autoimmunity-Blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: hOKT3gamma1 (Ala-Ala);   Other: Intensive diabetes management

Indicates status has not been verified in more than two years